Skip to search.
 TSX Up 0.47% TSX Ventures Up 1.46%

Novavax, Inc. (NVAX)

-NasdaqGS
5.24 Down 0.21(3.85%) Apr 29, 4:00PM EDT
|After Hours : 5.25 Up 0.01 (0.19%) Apr 29, 5:45PM EDT
Prev Close:5.45
Open:5.43
Bid:5.25 x 100
Ask:5.31 x 1000
1y Target Est:14.32
Beta:1.81733
Next Earnings Date: 4-May-16NVAX Earnings announcement
Day's Range:5.24 - 5.49
52wk Range:4.08 - 15.01
Volume:5,309,508
Avg Vol (3m):6,902,130
Market Cap:1.42B
P/E (ttm):N/A
EPS (ttm):-0.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXDown 3.85%1.42B
MRKDown 1.61%151.89B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):40.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.88
Quarterly EPS Est (Mar-16) :-0.27
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback